Refine
Year of publication
Document Type
- Article (1107)
- Doctoral Thesis (813)
- Book (58)
- Preprint (51)
- Contribution to a Periodical (43)
- Conference Proceeding (10)
- Diploma Thesis (10)
- Review (8)
- diplomthesis (4)
- Report (3)
Has Fulltext
- yes (2109)
Is part of the Bibliography
- no (2109)
Keywords
- Podospora anserina (15)
- aging (15)
- mitochondria (11)
- Archaea (9)
- Haloferax volcanii (9)
- Saccharomyces cerevisiae (9)
- autophagy (9)
- Phylogeny (8)
- heat stress (8)
- Mitochondria (7)
Institute
- Biowissenschaften (2109) (remove)
Stem cells are often referred to as potential candidates for the treatment of different pathologies. Their ability to differentiate into various tissue specific cell types offers the possibility to engineer cell systems or organs for replacement. One of the main questions in stem cell biology is how stemness properties are regulated and to what extend this regulation is intrinsic or conveyed by the direct microenvironment (‘niche’). In order to elucidate such regulatory processes, it is informative to analyze processes or molecules that are shared between different stem cell populations.
One such molecule that is expressed on a wide range of different embryonic and adult as well as tumor stem cells is the ABC transporter Abcg2. ABC transporters in general are transmembrane proteins that actively extrude endo- and exotoxins as well as xenobiotics, thereby protecting cells and organs. Additionally, ABC transporters are responsible for drug resistance in many cancers. A well-described characteristic of stem cells expressing Abcg2 is the formation of the ‘side population’ (SP) phenotype: An active Abcg2 transporter mediates the efflux of a particular fluorescent dye that is taken up by all cells, thus leading to a less brightly stained population. This phenomenon is widely used to characterize and isolate the most primitive stem cell subpopulation from embryonic and adult tissues, including tumors. Besides its role as toxin transporter little is known about the function of Abcg2 in stem cells. This is mainly due to the fact that its physiological substrate in stem cells remains unknown. The identification of such substrates is therefore of high interest because it would directly link the activity of ABC transporters to regulatory mechanisms in stem cell biology.
In the present study we wanted to test the hypothesis that the sphingolipid ceramide is a physiological substrate of the ABC transporter Abcg2. Sphingolipids are potent second messengers and are known to have regulatory functions in stem cells. In particular, the sphingolipid ceramide is described as a mediator of controlled cell death and inducer of differentiation. It is suggested that stem cells need to keep their intracellular ceramide content at low levels in order to prevent apoptosis or differentiation. We propose that Abcg2 and ceramide interact and that this interaction leads to changes in the absolute or relative amounts of ceramide. This in turn influences basic stem cell functions such as self renewal and differentiation.
We show that Abcg2 prevents cells from accumulating fluorescence labeled ceramide. Furthermore, exogenously applied ceramides inhibit the transport activity of Abcg2, measured by a decrease of the side population phenotype. This inhibitory effect is consistent with a competitive inhibition mechanism. Additionally, we show that active Abcg2 can increase the ceramide concentration in cell culture supernatant. Finally we demonstrate that Abcg2 protects from ceramide induced cytotoxicity in human cell lines. In summary, these in vitro results strongly suggest that Abcg2 has the ability to regulate ceramide levels.
Murine hematopoietic stem cells (HSCs) are the best characterized adult stem cell system so far. By using 7-colour fluorescence-activated cell sorting (FACS) we established the purification of the most primitive HSCs, reflected by their high engraftment capability when transplanted to lethally irradiated mice. By using this sorted cell populations it was in addition possible to establish a system to reproducibly manipulate HSCs ex vivo. This experimental system will serve in further elucidating the physiological consequences of Abcg2 mediated changes in ceramide levels on stem cells in vivo.
Taken together, this study shows that Abcg2 has the ability to regulate ceramide levels in cells. This in turn can lead to cellular protection from ceramide induced apoptosis. Additionally, the experimental techniques to further analyze the role of Abcg2 and ceramide in the most primitive hematopoietic stem cells were successfully established, enabling more detailed analysis in the future.
Conclusion: Proteins containing a Jumonji C (JmjC) domain appear in almost all living organisms and catalyze a variety of oxidation reactions. Therefore, they are important regulators in many biological processes such as proliferation and differentiation. They act either as protein hydroxylases, histone demethylases or by regulate mRNA splicing. Given the fact that some of the JmjC domain-containing proteins are shown to be upregulated in response to hypoxia as well as the dependency of JmjC domain catalytic activity on oxygen led to the assumption of an involvement in angiogenesis. For Jmjd6, a member of the JmjC domain-containing protein family, a regulatory involvement in mRNA splicing has been shown. The Jmjd6-/- mouse dies perinatally due to several severe organ malformations, especially in the heart. Despite the pale appearance, the growth retardation and the cardiac defects, it is unclear whether these mice exhibit defects of cells comprising the vasculature. Therefore, the involvement of Jmjd6 in angiogenesis was examined in vitro using angiogenesis assays as well as in vivo using the Jmjd6+/- mouse. An siRNA-mediated knockdown of Jmjd6 in ECs significantly impaired the formation of capillary-like networks in the tube formation assay as well as sprouting in the spheroid assay. Moreover, after siRNA-mediated knockdown of Jmjd6 in ECs cell migration was significantly reduced. These findings were confirmed in the matrigel plug assay in vivo. Implanted matrigel plugs of Jmjd6+/- mice exhibited significantly less perfused vessels compared to wildtype littermates. Furthermore, cultured lung ECs from Jmjd6+/- mice exhibited impaired network forming activity ex vivo compared to cells isolated from wildtype littermates. To elucidate the mechanisms underlying the requirement of Jmjd6 in angiogenesis, an Affymetrix exon-array was performed, which allows detection of changes in gene expression as well as splicing. The siRNA-mediated knockdown of Jmjd6 altered the expression of genes known to play a role in vascular biology. The bioinformatic assessment of alternative splice variants revealed that Jmjd6 silencing affects the splicing of the VEGF receptor 1 (Flt1). Differential splicing of Flt1 was shown to generate a short and soluble form of Flt1 (sFlt1), which sequestrates VEGF and PlGF, and thereby inhibits angiogenesis. In particular, a significant increase in sFlt1 expression was observed. Jmjd6 was recently reported to hydroxylate the splicing factor U2AF65. Therefore, we investigated whether U2AF65 might mediate Flt1 splicing and binds to Flt1 mRNA. Indeed, U2AF65 co-immunoprecipitated with Jmjd6 in ECs, while an interaction of U2AF65 with sFlt1 was demonstrated. Moreover, inhibition of Jmjd6 catalytic function by reduced oxygen concentration altered splicing of Flt1 resulted in an increase of the sFlt1 splice variant. Finally, saturating concentrations of VEGF or PlGF or neutralizing antibodies against sFlt1 significantly reduced the inhibition of sprouting caused by Jmjd6 knockdown in vitro.
Collectively, our results indicate that Jmjd6 has an essential role in the oxygen-dependent regulation of angiogenesis by controlling the splicing of Flt1 mRNA, thereby adjusting the generation of the anti-angiogenic short splice variant sFlt1. Several publications demonstrated a major importance for sFlt1 as a biomarker for many severe human diseases such as preeclampsia, sepsis, cancer, myocardial infarction as well as chronic heart failure. Therefore, the identification of the molecular mechanism behind the generation of sFlt1 might enable the development of new or more precise clinical markers for the diagnosis of the corresponding diseases. Furthermore, the discovery of the enzymes involved in the generation of sFlt1 provides further possibilities to modulate sFlt1 levels and thereby may potentially gives rise to the development of new therapies.
The translocation of nuclear-encoded precursor proteins into chloroplasts is a highly ordered process involving the action of several components to regulate this molecular ensemble. Not only GTP hydrolysis and GDP release but also the phosphorylation of TOC GTPases is a widely discussed mechanism to regulate protein import. The receptor component (Toc34) and its isoform of A. thaliana (atToc33) were found to be regulated by phosphorylation. Although the phosphorylation of Toc33 is already known for several years, several questions regarding the molecular components involved in the regulation of the phosphorylation process, precisely what is the protein kinase and where this kinase is initially localized, so far remained unclear.
This thesis aimed at the defining of the phosphorylation status of TOC GTPases in monomeric and/or dimeric states, the identification of the nature of Toc33-PK (protein kinase), and in the same context it aimed at gaining first insights into the physiological significance of Toc33 phosphorylation. To this end, (I) An in vitro and in vivo system for investigating of TOC GTPases Phosphorylation (in monomeric or dimeric state) was developed. Since no information is available about the phosphorylation status of the Toc159 isoforms, the second receptor of the TOC complex, it was interesting to investigate whether these isoforms undergo phosphorylation or not. The results indicated that atToc159 isoforms are able to be phosphorylated by the kinase activity in purified outer envelope membranes (OEMs) of pea, but not atToc132. Moreover, an artificial dimer of psToc34 based on the interaction of a C-terminally fused leucine zipper was not phosphorylated. This result reflected the inability of the OEM kinase to phosphorylate the dimers of TOC GTPases. Also, In vivo labeling of atToc33 was developed and occurred in a dose-dependent manner. Therefore, this results evidenced that in vitro phosphorylation of atToc33 (both endogenous wild type and recombinant expressed proteins) is not artificial labeling but represents a physiological relevance. CD (circular dichroism) measurements revealed that recombinant GTPase domain of atToc33 is preferentially phosphorylated in its folded state. Therefore, it could be suggested that folding of atToc33rec is a prerequisite for its phosphorylation and the phosphorylation event occurs as a posttranslational modification most likely after insertion of Toc33 (Toc34) into the OE of chloroplasts.
Secondly, (II) Isolation and identification of Toc33-PK from OEMs of chloroplasts was performed. Four independent strategies were developed to identify the Toc33-protein kinase: UV-induced and chemically-based crosslinking, different applied chromatographic techniques, identification of PK-Toc33 interaction by means of HDN-PAGE (histidine- and deoxycholate-based native PAGE), and finally mass spectrometric approaches were performed on fractions including the potential kinase activity. UV-induced crosslinking procedure was developed and resulted in covalent bonding of nine proteins to [a-32P] ATP, while chemically-based one was not significant. The applied chromatographic and HDN-PAGE approaches, including mass spectrometry, have revealed the identification of 13 protein kinases. Of these identified kinases, phototropin2 (Phot2, AT5G58140), leucine-rich repeat PK (LRR-PK, AT4G28650.1), and receptor-like transmembrane PK (RLK, AT5G56040.2) were selected as the most promising candidates (ca. kinase type and one transmembrane helix for membrane localization).
(III) The physiological significance of Toc33 phosphoryation was shown to link this process with the environmental changes (especially, the light conditions). Identification of chloroplast OE-located PKs performed by nLC-MALDI-MS/MS resulted in the detection of Phot2. Furthermore, the subcellular localization of Phot2 in OEM of chloroplasts was confirmed by immunoblotting experiments using a-Phot2 antibody. The kinase activity of Phot2 towards TOC GTPases was characterized and revealed that fused GST-KD (kinase domain) protein able to specifically phosphorylate atToc33rec, but not atToc159rec. Also, endogenous atPhot2 was upregulated and heavily detected in the ppi1-S181A plant line (where serine to alanine exchange was performed to abolish the phosphorylation of atToc33). Hence, we suggested that certain signal cascades may directly or indirectly link Toc33 receptor phosphorylation, protein levels of Phot2 (as promising PK candidate), and irradiation conditions (as an inducing signal of the subsequent phosphorylation events). Light-dependent phosphorylation of Toc33 was shown either after de-etiolation conditions or after high light intensities of blue light was performed. Therefore, phosphorylation of Toc33 might be identified as an external regulatory signal to regulate preproteins import into chloroplasts in response to environmental conditions (e.g. light changes) or as a signal of chloroplast biogenesis.
Development of lentiviral vectors for the gene therapy of X-linked chronic granulomatous disease
(2010)
Es gibt eine Vielzahl von Erkrankungen, die auf einen einzelnen Gendefekt zurückzuführen sind (monogene Erkrankungen). Darunter befindet sich auch die Gruppe der primären Immundefizienzen (PIDs), von denen aktuell über 150 verschiedene Typen von der Weltgesundheitsorganisation registriert sind. In vielen fällen leiden betroffene Individuen unter einem stark erhöhten Infektionsrisiko durch bakterielle oder virale Pathogene, sowie den damit verbundenen schweren Symptomen - bis hin zum verfrühten Tod der Patienten. Meist können PIDs mit konventionellen Methoden präventiv behandelt werden. Dazu gehören zum Beispiel die regelmässige Gabe von Antibiotika, Antimykotika, Zytokinen oder Immunglobulinen. Der einzige zur Verfügung stehende kurative Behandlungsansatz beruht auf der Transplantation von hämatopoietischen Stammzellen (HSZT) eines gesunden und passenden Spenders. Häufig steht jedoch kein histokompatibler Spender zur Verfügung.
Für diese Patientengruppe hat sich die gentherapeutische Behandlung mit autologen hämatopoietischen Stammzellen als eine gute Option herausgestellt. Der Beweis hierfür wurde eindrucksvoll in klinischen Heilversuchen für zwei Formen des Schweren Kombinierten Immundefekts (X-SCID und ADA-SCID) geführt, einer Erkrankung die durch das vollständige Fehlen bzw. die nicht-Funktionalität der lymphoiden Immunzellen charakterisiert ist. Autologe hämatopoietische Stammzellen der Patienten wurden hier ex vivo mittels eines gamma-retroviralen Vektors mit einer funktionellen Kopie der defekten cDNA genetisch modifiziert und anschliessend zurück infundiert. In der Summe wurde bei über 30 Patienten eine deutliche Verbesserung des Gesundheitszustandes bis hin zur vollständigen Heilung erzielt. Bei einem vergleichbaren Ansatz wurden in Frankfurt, in einem Heilversuch für die septische Granulomatose (X-CGD), erstmals klinisch relevante Erfolge in der Gentherapie für einen Defekt in der myeloischen Linie von Immunzellen erzielt. Ursache der X-chromosomal gekoppelten Form der septischen Granulomatose sind Mutationen in dem Gen für gp91phox (CYBB), einer essentiellen Untereinheit des in Phagozyten benötigten NADPH-Oxidase Komplexes. In der Folge sind die Phagozyten dieser Patienten nicht mehr in der Lage, die für das Abtöten von Krankheitserregern nötigen reaktiven Sauerstoffspezies zu bilden. Ständig wiederkehrende schwere Infektionen mit sonst unproblematischen Erregern sind die Folge.
Neben klaren gesundheitlichen Verbesserungen in der Mehrzahl der Patienten hatte diese Gentherapeutische Behandlungsstrategie in einigen Fällen auch klare Nebenwirkungen. In fünf von 20 Patienten mit X-SCID, sowie in beiden behandelten X-CGD Patienten, kam es infolge der Therapie zu hämatologischen Veränderungen, die in der Ausbildung eines myelodysplastischen Syndroms (bei X-CGD) und Leukämie (bei X-SCID) mündeten. In allen Fällen war die Ursache eine Hochregulierung von Proto-Onkogenen in der Nähe von g-retroviralen Integrationsstellen. Diese Probleme demonstrieren deutlich die unbedingte Notwendigkeit zur Verbesserung der verwendeten therapeutischen Vektoren.
In der vorliegenden Arbeit wurden lentivirale Vektoren mit myeloid-spezifischen Promotoren entwickelt und auf ihre Eignung für die Gentherapie der X-chromosomal gekoppelten septischen Granulomatose getestet. Lentivirale Vektoren besitzen ein stark verringertes Risiko für Insertionsmutagenese, sowie die exklusive Fähigkeit ruhende Zellen zu transduzieren. Die Verwendung von myeloid-spezifischen Promotoren für die Transgenexpression verringert die Wahrscheinlichkeit der Proto-Onkogen Aktivierung in unreifen Stamm- und Vorläuferzellen – einer Zellpopulation die besonders sensitiv für die in der Leukämieentstehung obligaten Schritte der Immortalisierung und Transformation ist. Gleichzeitig bleibt der volle therapeutische Nutzen erhalten, da das Transgen gp91phox nur in reifen myeloischen Zellen benötigt wird.
Die entwickelten lentiviralen Vektoren exprimieren eine kodonoptimierte gp91phox cDNA unter der Kontrolle des microRNA223-Promoters (223), des MRP8-Promotors (M) oder eines chimären Fusionspromoters bestehend aus den regulatorischen Bereichen des Cathepsin G und des cFes-Promotors (Chim). Zusätzlich wurde ein sogenanntes „ubiquitär aktives Chromatin-öffnendes Element“ (UCOE) in beiden Orientierungen vor den MRP8-Promotor kloniert, um eine erhöhte und stabile Langzeitexpression des Transgens zu erreichen. Ziel der Arbeit war die Selektion eines geeigneten Kandidaten für präklinische Versuchsreihen.
Die für die Evaluierung der Vektoren relevanten Parameter waren die Transgenexpressionslevel, die Spezifität der Expression für myeloische Zellen sowie die vermittelte funktionelle Rekonstitution der NADPH-Oxidase Aktivität. Die Fragestellungen der Langzeitexpression, der Anfälligkeit für CpG-Methylierung sowie der Genotoxizität der Vektoren wurden ebenfalls bearbeitet. Die Vektoren wurden in vitro in verschiedenen Zelllinien sowie in in vitro differenzierten primären murinen und humanen Blutstammzellen getestet. Die beiden besten Kandidaten (223 und Chim) wurden in vivo in Maustransplantationsexperimenten (Maus-Maus und humane Stammzellen in NOD/SCID-Mäuse) analysiert.
Die beiden lentiviralen Vektoren 223 und Chim eignen sich beide für eine effiziente Expression in myeloische Zellen, die zur funktionellen Rekonstitution der NADPH-Oxidase Aktivität in vitro und in vivo führen. Sie sind den bisher in klinischen Anwendungen verwendeten Vektoren in allen Parametern klar überlegen. Daher ist in zukünftigen klinischen Anwendungen ein verbesserter therapeutischer Nutzen für die Patienten sowie eine Verminderung des Risikos von Nebenwirkungen zu erwarten.
Plastids are complex organelles that fulfil numerous essential cellular functions, such as
photosynthesis, amino acid and fatty acid synthesis. he majority of proteins required for
these functions are encoded in the nuclear genome and synthesised on cytosolic ribosomes as
precursors, which are posttranslationally transported to and imported into the organelle by
concerted actions of translocons in the outer and inner chloroplast membrane. For most
preproteins, targeting to the organelle is ensured by a specific import signal, a so called
transit peptide, which is specifically recognised by receptors at the chloroplastês surface. A transit peptide is generally defined as essential and sufficient for precursor targeting to and
translocation into chloroplasts, (however, an analysis of the ability of transit peptides to drive translocation of tightly folded passenger domain revealed that the transit peptide is not
always sufficient for the translocation event. A critical signal length requirement of amino
acids has been determined in vivo and in vitro. In the case of shorter transit peptide, the
succeeding portion of the mature domain provides an extension of an unfolded polypeptide
stretch required for successful translocation. The analysis of the unfolding mode of a folded
model passenger during translocation links the observed transit peptide length requirement
to the action of an energising unit present in the intermembrane space of chloroplasts.
The likely candidate for this energising unit space is putative imsHsp70, previously hypothesised to function in translocation of precursor proteins across the outer membrane. However, as the identity of this protein has up to now remained unknown, its existence has
been a matter of debate. The present study focuses on the isolation and characterisation of
imsHsp70 at the molecular level. Mass spectrometry analyses and in vivo localisation studies
demonstrate that while no specific imsHsp70 exists, multiple cytosolic Hsp70 isoforms are
targeted to the intermembrane space, but not to the stroma of chloroplasts. Thus, a so far unrecognised mode of dual targeting to chloroplasts and cytosol is most likely to ensure the
allocation of (sp s into the intermembrane space.
Crista junctions (CJs) are tubular invaginations of the inner membrane of mitochondria that connect the inner boundary with the cristae membrane. These architectural elements are critical for mitochondrial function. The yeast inner membrane protein Fcj1, called mitofilin in mammals, was reported to be preferentially located at CJs and crucial for their formation. Here we investigate the functional roles of individual domains of Fcj1. The most conserved part of Fcj1, the C-terminal domain, is essential for Fcj1 function. In its absence, formation of CJ is strongly impaired and irregular, and stacked cristae are present. This domain interacts with full-length Fcj1, suggesting a role in oligomer formation. It also interacts with Tob55 of the translocase of outer membrane β-barrel proteins (TOB)/sorting and assembly machinery (SAM) complex, which is required for the insertion of β-barrel proteins into the outer membrane. The association of the TOB/SAM complex with contact sites depends on the presence of Fcj1. The biogenesis of β-barrel proteins is not significantly affected in the absence of Fcj1. However, down-regulation of the TOB/SAM complex leads to altered cristae morphology and a moderate reduction in the number of CJs. We propose that the C-terminal domain of Fcj1 is critical for the interaction of Fcj1 with the TOB/SAM complex and thereby for stabilizing CJs in close proximity to the outer membrane. These results assign novel functions to both the C-terminal domain of Fcj1 and the TOB/SAM complex.
BACKGROUND: The identification of beta-barrel membrane proteins out of a genomic/proteomic background is one of the rapidly developing fields in bioinformatics. Our main goal is the prediction of such proteins in genome/proteome wide analyses.
RESULTS: For the prediction of beta-barrel membrane proteins within prokaryotic proteomes a set of parameters was developed. We have focused on a procedure with a low false positive rate beside a procedure with lowest false prediction rate to obtain a high certainty for the predicted sequences. We demonstrate that the discrimination between beta-barrel membrane proteins and other proteins is improved by analyzing a length limited region. The developed set of parameters is applied to the proteome of E. coli and the results are compared to four other described procedures.
CONCLUSION: Analyzing the beta-barrel membrane proteins revealed the presence of a defined membrane inserted beta-barrel region. This information can now be used to refine other prediction programs as well. So far, all tested programs fail to predict outer membrane proteins in the proteome of the prokaryote E. coli with high reliability. However, the reliability of the prediction is improved significantly by a combinatory approach of several programs. The consequences and usability of the developed scores are discussed.
Enzymes involved in tRNA maturation are essential for cytosolic, mitochondrial, and plastid protein synthesis and are therefore localized to these different compartments of the cell. Interestingly, only one isoform of tRNA nucleotidyltransferase (responsible for adding the 3′-terminal cytidine–cytidine–adenosine to tRNAs) has been identified in plants. The present study therefore explored how signals contained on this enzyme allow it to be distributed among the different cell compartments. It is demonstrated that the N-terminal portion of the protein acts as an organellar targeting signal and that differential use of multiple in-frame start codons alters the localization of the protein. Moreover, it is shown that the mature domain has a major impact on the distribution of the protein within the cell. These data indicate that regulation of dual localization involves not only specific N-terminal signals, but also additional factors within the protein or the cell.
Eukaryotic ribosome biogenesis requires the concerted action of numerous ribosome assembly factors, for most of which structural and functional information is currently lacking. Nob1, which can be identified in eukaryotes and archaea, is required for the final maturation of the small subunit ribosomal RNA in yeast by catalyzing cleavage at site D after export of the preribosomal subunit into the cytoplasm. Here, we show that this also holds true for Nob1 from the archaeon Pyrococcus horikoshii, which efficiently cleaves RNA-substrates containing the D-site of the preribosomal RNA in a manganese-dependent manner. The structure of PhNob1 solved by nuclear magnetic resonance spectroscopy revealed a PIN domain common with many nucleases and a zinc ribbon domain, which are structurally connected by a flexible linker. We show that amino acid residues required for substrate binding reside in the PIN domain whereas the zinc ribbon domain alone is sufficient to bind helix 40 of the small subunit rRNA. This suggests that the zinc ribbon domain acts as an anchor point for the protein on the nascent subunit positioning it in the proximity of the cleavage site.
Organelles are surrounded by membranes with a distinct lipid and protein composition. While it is well established that lipids affect protein functioning and vice versa, it has been only recently suggested that elevated membrane protein concentrations may affect the shape and organization of membranes. We therefore analyzed the effects of high chloroplast envelope protein concentrations on membrane structures using an in vivo approach with protoplasts. Transient expression of outer envelope proteins or protein domains such as CHUP1-TM–GFP, outer envelope protein of 7 kDa–GFP, or outer envelope protein of 24 kDa–GFP at high levels led to the formation of punctate, circular, and tubular membrane protrusions. Expression of inner membrane proteins such as translocase of inner chloroplast membrane 20, isoform II (Tic20-II)–GFP led to membrane protrusions including invaginations. Using increasing amounts of DNA for transfection, we could show that the frequency, size, and intensity of these protrusions increased with protein concentration. The membrane deformations were absent after cycloheximide treatment. Co-expression of CHUP1-TM–Cherry and Tic20-II–GFP led to membrane protrusions of various shapes and sizes including some stromule-like structures, for which several functions have been proposed. Interestingly, some structures seemed to contain both proteins, while others seem to contain one protein exclusively, indicating that outer and inner envelope dynamics might be regulated independently. While it was more difficult to investigate the effects of high expression levels of membrane proteins on mitochondrial membrane shapes using confocal imaging, it was striking that the expression of the outer membrane protein Tom20 led to more elongate mitochondria. We discuss that the effect of protein concentrations on membrane structure is possibly caused by an imbalance in the lipid to protein ratio and may be involved in a signaling pathway regulating membrane biogenesis. Finally, the observed phenomenon provides a valuable experimental approach to investigate the relationship between lipid synthesis and membrane protein expression in future studies.